Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer.
Saved in:
| Title: | Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer. |
|---|---|
| Authors: | Frederiks ML; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.l.frederiks@umcg.nl., Berbée M; Department of Radiation Oncology (MAASTRO), Maastro Clinic, Maastricht, the Netherlands., Schuit E; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Laarhoven HWM; Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., van Rossum PSN; Department of Radiation Oncology, Amsterdam UMC (VUmc) Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., van Kesteren Z; Department of Radiation Oncology, Amsterdam UMC (VUmc) Amsterdam, Amsterdam, the Netherlands., van Berge Henegouwen MI; Amsterdam UMC Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, the Netherlands., Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Mook S; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Ruurda JP; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nuyttens JJ; Department of Radiation Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands., Rütten H; Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands., Klarenbeek B; Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands., Hartogh MDD; Radiotherapiegroep, Arnhem/Deventer, the Netherlands., Sosef M; Department of Surgery, Zuyderland Medical Center, Heerlen, the Netherlands., Canters R; Department of Radiation Oncology (MAASTRO), Maastro Clinic, Maastricht, the Netherlands., Verhoeven RHA; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, the Netherlands; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands., van Etten B; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Wijnhoven BPL; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands. |
| Corporate Authors: | MODELS consortium |
| Source: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Jul; Vol. 220, pp. 111554. Date of Electronic Publication: 2026 May 02. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
